Table 4.
Univariate and multivariate analysis by subgroup for overall survival
Univariate analysis |
Multivariate analysis |
|||||||
HR | 95%CI | P vaule | HR | 95%CI | P vaule | |||
Tumor location | < 10-4 | < 10-4 | ||||||
CR | Ref | Ref | ||||||
Pancréas | 6.362 | 2.963 | 13.66 | 5.816 | 2.47 | 13.693 | ||
Metastatic sites | 0.0634 | 0.9874 | ||||||
0-1 | Ref | Ref | ||||||
≥ 2 | 0.555 | 0.298 | 1.034 | 1.006 | 0.498 | 2.032 | ||
Age | 0.5721 | 0.7614 | ||||||
< 75 | Ref | Ref | ||||||
≥ 75 | 1.184 | 0.659 | 2.124 | 1.096 | 0.607 | 1.976 | ||
Age | 0.5365 | 0.274 | ||||||
< 80 | Ref | Ref | ||||||
≥ 80 | 1.277 | 0.588 | 2.774 | 1.611 | 0.686 | 3.786 | ||
Sexe | 0.1178 | 0.4136 | ||||||
Male | Ref | Ref | ||||||
Female | 0.464 | 0.177 | 1.215 | 0.634 | 0.212 | 1.891 | ||
Comorbidities | 0.0899 | 0.8701 | ||||||
No | Ref | Ref | ||||||
Yes | 1.787 | 0.914 | 3.495 | 1.066 | 0.494 | 2.301 | ||
Initial autonomy | 0.7372 | |||||||
No | Ref | |||||||
Yes | 1.277 | 0.306 | 5.336 | |||||
Charlson comorbidities index | 0.7507 | |||||||
< 10 | Ref | |||||||
≥ 10 | 1.101 | 0.608 | 1.992 | |||||
ECOG performance status | 0.6426 | |||||||
0-1 | Ref | |||||||
≥ 2 | 0.833 | 0.385 | 1.802 | |||||
Number of usual drugs | 0.6116 | |||||||
< 4 | Ref | |||||||
≥ 4 | 1.169 | 0.64 | 2.132 |